Inhibitors of growth factor activation as new adjunct chemotherapy for cancer

September 27th, 2016 – Jim Janetka, PhD, Associate Professor, Department of Biochemistry and Molecular Biophysics, received a new two year grant award from the Alvin J. Siteman Cancer Research Fund for his research entitled “Inhibitors of growth factor activation as new adjunct chemotherapy for cancer”.

More information here: “Siteman fund grants $300,000 for unique approaches to fighting cancer